title: [Evidence for psychopharmacological treatment of depression in children and adolescents?].
abstract: Depression in children and adolescents is relatively prevalent and may have serious consequences. Treatment of depressive disorders may be psychotherapeutic or psychopharmacological. A systematic literature search was performed and the evidence for a psychopharmacological treatment of depressive disorders in children and adolescents was described. Emphasis is put on treatment with selective serotonin reuptake inhibitors as these are the best-documented agents in the treatment of depression in children and adolescents.
authors: Arhus Universitetshospital, Børne- og Ungdomspsykiatrisk Hospital, Risskov. pht@buh.aaa.dk
authors: Per Hove
authors: PH
authors: Thomsen
authors: Merete Juul
authors: MJ
authors: Sørensen
mesh_terms: D000293:Adolescent; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D015928:Cognitive Behavioral Therapy; D003863:Depression / Q000188:drug therapy* / Q000628:therapy; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000628:therapy; D019317:Evidence-Based Medicine; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D000929:Antidepressive Agents, Tricyclic; D017367:Selective Serotonin Reuptake Inhibitors